Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities

Area of Science:

• Malariology
• Parasitology
• Drug Discovery

Background:

• Targeting human-mosquito parasite transmission is crucial for global malaria elimination.
• The optimal profile for transmission-blocking antimalarials remains undefined, with questions about targeting specific parasite stages or employing polypharmacology.
• Current strategies for developing transmission-blocking antimalarials require objective analysis.

Purpose of the Study:

• To analyze pertinent issues and questions regarding the target candidate profile of transmission-blocking compounds.
• To propose novel perspectives on the role of transmission-blocking drugs in malaria elimination strategies.
• To emphasize the importance of an integrated test cascade for identifying next-generation antimalarials.

Main Methods:

• Review and analysis of current strategies for transmission-blocking antimalarial development.
• Identification and discussion of key questions surrounding drug candidate profiles.
• Proposal of an integrated screening and validation test cascade.

Main Results:

• Highlighted critical issues in defining the ideal transmission-blocking antimalarial drug profile.
• Proposed novel perspectives on integrating these drugs into malaria elimination efforts.
• Emphasized the necessity of a robust test cascade for effective drug discovery.

Conclusions:

• Objective analysis of current strategies is essential for advancing transmission-blocking antimalarial development.
• A well-defined test cascade is critical for identifying and validating effective next-generation antimalarials.
• Strategic development of transmission-blocking drugs is vital for achieving global malaria elimination.